Literature DB >> 737495

Retroperitoneal fibrosis after treatment with atenolol.

C C Doherty, M G McGeown, R A Donaldson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 737495      PMCID： PMC1610048          DOI： 10.1136/bmj.2.6154.1786-b

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Drug-induced localized systemic scleroses.

Authors:  J R Graham
Journal:  Trans Am Clin Climatol Assoc       Date:  1981

Review 2.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

3.  Drugs associated with retroperitoneal fibrosis.

Authors:  R L Ristagno
Journal:  West J Med       Date:  1981-08

Review 4.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

5.  Retroperitoneal fibrosis associated with scirrhous gastric cancer.

Authors:  K Dohmen; Y Mizukami; K Tanaka; H Nakamura; K Arase; Y Yokogawa; R Asayama; A Kato; M Kato; M Nakagaki
Journal:  Gastroenterol Jpn       Date:  1993-10

6.  Regulation of collagen production by the beta-adrenergic system.

Authors:  R A Berg; J Moss; B J Baum; R G Crystal
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

Review 7.  Drug-induced bladder and urinary disorders. Incidence, prevention and management.

Authors:  M J Drake; P M Nixon; J P Crew
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.